Alzamend Neuro
Newport Beach
About Alzamend Neuro
Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease. The company also focused on the facilitation of bringing technologies to market which help with the treatment, prevention, or cure of Alzheimer’s. They providing hope through the commercialization of existing patented intellectual property while simultaneously funding future treatments through advanced research and development. Alzamend Neuro was founded in 2016 and is headquartered in Newport Beach, CA, USA.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $30.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2025)
- Ticker: nasdaq:ALZN
- Website: alzamend.com
- Phone: (844) 722-6333
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/alzamend-neuro-118985 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.